1. Home
  2. AENT vs AKBA Comparison

AENT vs AKBA Comparison

Compare AENT & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Entertainment Holding Corporation

AENT

Alliance Entertainment Holding Corporation

N/A

Current Price

$5.62

Market Cap

303.3M

ML Signal

N/A

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$0.90

Market Cap

343.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AENT
AKBA
Founded
1990
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
303.3M
343.4M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
AENT
AKBA
Price
$5.62
$0.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$10.00
$4.67
AVG Volume (30 Days)
10.4K
4.8M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
233.33
93.94
EPS
0.32
N/A
Revenue
$2,700,000.00
N/A
Revenue This Year
$3.44
N/A
Revenue Next Year
$1.64
N/A
P/E Ratio
$17.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.36
$0.81
52 Week High
$8.80
$3.22

Technical Indicators

Market Signals
Indicator
AENT
AKBA
Relative Strength Index (RSI) 47.38 39.38
Support Level $5.59 $0.85
Resistance Level $6.25 $1.54
Average True Range (ATR) 0.35 0.06
MACD 0.01 -0.01
Stochastic Oscillator 46.74 22.79

Price Performance

Historical Comparison
AENT
AKBA

About AENT Alliance Entertainment Holding Corporation

Alliance Entertainment Holding Corp is a distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world. The company has two divisions: Alliance Home Entertainment, which offers full-service support across production, marketing, and retail execution. and Alliance Authentic, which focuses on licensed collectibles and branded merchandise, including partnerships with Handmade by Robots, Master Replicas, and Weta Workshop.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: